| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/18/2006 | CA2585546A1 Indinavir derivatives useful in immunoassay |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657254A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 05/17/2006 | EP1657253A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/17/2006 | EP1657251A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/17/2006 | EP1657235A2 Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656560A2 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 05/17/2006 | EP1656392A2 Tie1-binding ligands |
| 05/17/2006 | EP1656391A2 Modified human igf-1r antibodies |
| 05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1124853B1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/17/2006 | EP1113818B1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 05/17/2006 | EP1071712B1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it |
| 05/17/2006 | EP1067183B1 Novel g protein-coupled receptor proteins |
| 05/17/2006 | EP1048727B1 Gene encoding novel transmembrane protein |
| 05/17/2006 | EP1029064B1 Protein production in transgenic alfalfa plants |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0973391B1 Endoderm, cardiac and neural inducing factors |
| 05/17/2006 | EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 05/17/2006 | EP0831148B1 Human adhesion molecule occludin |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | CN1774447A S. pneumoniae antigens |
| 05/17/2006 | CN1772766A Acetylcholinesterase monoclonal antibody related to resisting apoptosis and its use |
| 05/17/2006 | CN1256606C Metal die and manufacture thereof |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045611 Nucleic acid molecule, comprising a nucleic acid coding for a polypeptide with chorismate mutase activity |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045603 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/16/2006 | US7045602 Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| 05/16/2006 | US7045597 Mast cell surface antigen, DNA thereof, and antibody against the antigen |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045595 For development of therapeutic drugs for diseases associated with immunity or hematopoiesis |
| 05/16/2006 | US7045594 Serine proteinase inhibitors |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045350 Alternatively spliced circulating tissue factor |
| 05/16/2006 | US7045348 for gene transfer to dendritic cells; for immunotherapy; chimeras; genetic engineering; contains a fiber protein modified by insertion of a first zipper peptide that can crosslink to a fusion protein and a target ligand |
| 05/16/2006 | US7045333 Human protease molecules |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045301 Genetic engineering; prevention, therapy of cancer |
| 05/16/2006 | US7045286 Detecting expression of preferential proteins in sample; immbolize particle expressing protein, incubate with indicator, amplify oligonucleotides, mix with fluorescent dye, measure fluorescence from stained oligonucleotide |
| 05/16/2006 | US7045132 Comprises nucleotide sequences coding adhesion polypeptides for treating infection; bactericides; genetic vaccines |
| 05/16/2006 | US7045131 For passive immunization of patients infected with or susceptible to infection from Staphylococcus bacteria such as S.aureus and S.epidermidis |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045127 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050491A2 Methods for antibody engineering |
| 05/11/2006 | WO2006050420A2 Chimeric immunogens that comprise ovalbumin |
| 05/11/2006 | WO2006050343A2 Monoclonal antibodies to the propeptide of candida albicans and methods of use |
| 05/11/2006 | WO2006050291A1 Use of cr1-binding molecules in clearance and induction of immune responses |
| 05/11/2006 | WO2006050219A2 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 05/11/2006 | WO2006050046A2 Dre recombinase and recombinase systems employing dre recombinase |
| 05/11/2006 | WO2006050041A2 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 05/11/2006 | WO2006049440A1 Method for producing epidermal growth factor using fusion proteins comprising f a s-1 domain |
| 05/11/2006 | WO2006049273A1 Method of efficiently screening protein capable of specific binding to ligand |
| 05/11/2006 | WO2006048757A2 Anti-bacterial vaccine compositions |
| 05/11/2006 | WO2006048749A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 05/11/2006 | WO2006048576A1 Method for preparing specific affinity anti-progesterone antibodies, the obtained antibodies and the use thereof for in vitro diagnosis |
| 05/11/2006 | WO2006048300A1 Atazanavir conjugates and antibibodies useful in immunossay |
| 05/11/2006 | WO2006048295A1 Composition compri sing vlp and amyloid - beta peptide |
| 05/11/2006 | WO2006048174A2 Immunoglobulin fractions |
| 05/11/2006 | WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof |
| 05/11/2006 | WO2005123141A3 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 05/11/2006 | WO2005112568A3 Haplotype markers and methods of using the same to determine response to treatment |
| 05/11/2006 | WO2005095459A3 Monoclonal antibodies to gastrin hormone |
| 05/11/2006 | WO2005092925A3 Immunoglobulin variants outside the fc region |
| 05/11/2006 | WO2005010023A3 Method for prediction of an epitope |
| 05/11/2006 | WO2004110363A3 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 05/11/2006 | WO2004042028A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/11/2006 | WO2004032857A3 Antibody therapy |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060100420 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 05/11/2006 | US20060100417 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof |
| 05/11/2006 | US20060100280 Cell growth regulator |
| 05/11/2006 | US20060100135 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/11/2006 | US20060099708 Methods for diagnosis and treatment of MDK1 signal transduction disorders |
| 05/11/2006 | US20060099688 polypeptides having transferse enzyme activity, used for biosynthesis of polysaccharides; genetic engineering |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099676 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 05/11/2006 | US20060099663 Peptide sequence tags and method of using same |
| 05/11/2006 | US20060099662 Using anti-idiotypic antibody to determine CD20 concentration of cell; screening for modulators for prevention and/or treatment of HIV infection and cancer |
| 05/11/2006 | US20060099661 Detection and quantification of intracellular pathogens |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099652 IL 13 receptor alpha 2 antibody and methods of use |
| 05/11/2006 | US20060099651 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/11/2006 | US20060099648 Compositions and methods for epitope mapping |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099633 Human FcgammaRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof |